Aanwerving proef = ; Lopend onderzoek = ; Terminated trial = ; Gefinancierd door een IRDiRC-lid = ; Lid van een ERN =

Nationale klinische studie(s)

BELGIË

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS

STEP: Sorafenib Long Term Extension Program - BE

Cliniques universitaires Saint-Luc - UCLouvain

Pneumologie_Oncologie thoracique

Meer details

ITALIË

LAZIO
ROMA

An Open-Label, Single-Arm, Phase 1/2 Study Evaluating the Safety and Efficacy of Ponatinib for the Treatment of Recurrent or Refractory Leukemias or Solid Tumors in Pediatric Participants - IT

IRCCS Ospedale Pediatrico Bambino Gesù - SEDE GIANICOLO

U.O. di Oncoematologia

Meer details

Multinationale klinische studie(s)

SPANJE

Madrid
COLMENAR VIEJO

APL-A-005-02: Phase I - II clinical and pharmacokinetic study of Aplidin (APL) as a 3-hour intravenous infusion every 2 weeks, in children with refractory or relapsed malignant tumours and leukemia (coordination)

PharmaMar S.A.

Pharma Mar S.A.

Meer details